These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15855040)

  • 21. MRI--diagnostic and follow-up tool for microprolactinomas.
    Seidl Z; Obenberger J; Marek J; Hána V; Vanĕcková M
    Funct Neurol; 2000; 15(1):47-51. PubMed ID: 10842760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tenotomy of the tensor tympani and stapedius tendons in Ménière's disease.
    De Valck CF; Van Rompaey V; Wuyts EL; Van de Heyning PH
    B-ENT; 2009; 5(1):1-6. PubMed ID: 19455992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of hyperprolactinemia in anovulatory women.
    Greer ME; Moraczewski T; Rakoff JS
    Obstet Gynecol; 1980 Jul; 56(1):65-9. PubMed ID: 7189848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
    Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
    Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stress as a trigger of attacks in Menière's disease. A case-crossover study.
    Söderman AC; Möller J; Bagger-Sjöbäck D; Bergenius J; Hallqvist J
    Laryngoscope; 2004 Oct; 114(10):1843-8. PubMed ID: 15454783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of retrosigmoid vestibular neurectomy for intractable vertigo in Ménière's disease: an interdisciplinary review.
    Li CS; Lai JT
    Acta Neurochir (Wien); 2008 Jul; 150(7):655-61; discussion 661. PubMed ID: 18536995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
    Tütüncüler F; Darendeliler F; Aygün M; Hekim N
    Turk J Pediatr; 2006; 48(2):143-7. PubMed ID: 16848115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychological characteristics of patients with Ménière's disease compared with patients with vertigo, tinnitus, or hearing loss.
    Savastano M; Marioni G; Aita M
    Ear Nose Throat J; 2007 Mar; 86(3):148-56. PubMed ID: 17427776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased antisecretory factor reduces vertigo in patients with Ménière's disease: a pilot study.
    Hanner P; Jennische E; Lange S; Lönnroth I; Wahlström B
    Hear Res; 2004 Apr; 190(1-2):31-6. PubMed ID: 15051128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Idiopathic hyperprolactinemia in a 15-year-old boy: a case report and literature review.
    Jaruratanasirikul S; Janejindamai S
    J Med Assoc Thai; 1995 Jul; 78(7):388-92. PubMed ID: 7658185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
    Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
    Kyrodimos E; Aidonis I; Sismanis A
    J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Causes and clinical manifestations of the hyperprolactinemia syndrome. 3 cases of hypophyseal adenoma].
    Ivković T; Lepsanović L; Kovac T; Borota R
    Srp Arh Celok Lek; 1978 Oct; 106(10):913-23. PubMed ID: 752946
    [No Abstract]   [Full Text] [Related]  

  • 34. Transtympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease patients: long term outcome.
    Suryanarayanan R; Srinivasan VR; O'Sullivan G
    J Laryngol Otol; 2009 Jan; 123(1):45-9. PubMed ID: 18533050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperprolactinemia, infertility, and hypothyroidism. A case report and literature review.
    Fish LH; Mariash CN
    Arch Intern Med; 1988 Mar; 148(3):709-11. PubMed ID: 3341872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cochlear conductive hearing loss in patients with Meniere's disease.
    Yetişer S; Kertmen M
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(1):18-21. PubMed ID: 17483606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life instruments in Ménière's disease.
    Green JD; Verrall A; Gates GA
    Laryngoscope; 2007 Sep; 117(9):1622-8. PubMed ID: 17667131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
    Akkuzu B; Ozgirgin N; Ozlüoğlu LN
    Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C; Franco-Vidal V; Bebear JP; Darrouzet V
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
    Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
    Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.